Post-mortem molecular profiling of three psychiatric disorders

Genome Medicine

Volumn 9, Issue 1, 2017, Pages

  Ramaker, Ryne C ^a,b   Bowling, Kevin M ^a   Lasseigne, Brittany N ^a   Hagenauer, Megan H ^c   Hardigan, Andrew A ^a,b   Davis, Nicholas S ^a,h   Gertz, Jason ^a,i   Cartagena, Preston M ^d   Walsh, David M ^d   Vawter, Marquis P ^d   Schatzberg, Alan F ^e   Barchas, Jack D ^f   Watson, Stanley J ^c   Bunney, Blynn G ^d   Akil, Huda ^c   Bunney, William E ^d   Li, Jun Z ^g   Cooper, Sara J ^a   Myers, Richard M ^a  

^a HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h DUKE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; EGR1; Major depressive disorder; Metabolomics; RNA sequencing; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EGR1; TRANSCRIPTOME; UNCLASSIFIED DRUG; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, HUMAN;

ANTERIOR CINGULATE; ARTICLE; ASTROCYTE; AUTOPSY; BIPOLAR DISORDER; BRAIN TISSUE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DORSOLATERAL PREFRONTAL CORTEX; DOWN REGULATION; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KLHL14 GENE; MAJOR DEPRESSION; MOLECULAR GENETICS; NUCLEUS ACCUMBENS; PATHOGENESIS; PDPK2P GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RNA SEQUENCE; SCHIZOPHRENIA; SST GENE; UPREGULATION; BRAIN; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENETICS; MALE; METABOLISM; METABOLOMICS; SEQUENCE ANALYSIS;

AUTOPSY; BIPOLAR DISORDER; BRAIN; CHROMATIN IMMUNOPRECIPITATION; DEPRESSIVE DISORDER, MAJOR; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; HUMANS; MALE; METABOLOMICS; SCHIZOPHRENIA; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 85026365461     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-017-0458-5     Document Type: Article

References (57)

1. National Center for Health Statistics. Health, United States, 2005: With Chartbook on Long-term Trends in Health. Hyattsville, Maryland. 2005.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing. 2013.
3. Caldwell CB, Gottesman II. Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr Bull. 1990;16:571-89.
4. Siris SG. Suicide and schizophrenia. J Psychopharmacol. 2001;15:127-35.
5. Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-H, Holmans PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421-7.
6. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-52.
7. Cross-disorder Psychiatric Genomics Group. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381:1371-9.
8. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984-94.
9. Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39:1296-306.
10. Hwang Y, Kim J, Shin JY, Kim JI, Seo JS, Webster MJ, et al. Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia. Transl Psychiatry. 2013;3, e321.
11. Kohen R, Dobra A, Tracy JH, Haugen E. Transcriptome profiling of human hippocampus dentate gyrus granule cells in mental illness. Transl Psychiatry. 2014;4, e366.
12. Akula N, Barb J, Jiang X, Wendland JR, Choi KH, Sen SK, et al. RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol Psychiatry. 2014;19:1179-85.
13. Darby MM, Yolken RH, Sabunciyan S. Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders. Transl Psychiatry. 2016;6, e890.
14. Fromer M, Roussos P, Sieberts SK, Johnson JS, Kavanagh DH, Perumal TM, et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci. 2016;19(11):1442-53.
15. Olsen CM. Natural rewards, neuroplasticity, and non-drug addictions. Neuropharmacology. 2011;61:1109-22.
16. Wenzel JM, Rauscher NA, Cheer JF, Oleson EB. A role for phasic dopamine release within the nucleus accumbens in encoding aversion: a review of the neurochemical literature. ACS Chem Neurosci. 2015;6:16-26.
17. Evans SJ, Choudary PV, Vawter MP, Li J, Meador-Woodruff JH, Lopez JF, et al. DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles. Neurobiol Dis. 2003;14:240-50.
18. Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Choudary PV, et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet. 2004;13:609-16.
19. Jones EG, Hendry SH, Liu XB, Hodgins S, Potkin SG, Tourtellotte WW. A method for fixation of previously fresh-frozen human adult and fetal brains that preserves histological quality and immunoreactivity. J Neurosci Methods. 1992;44:133-44.
20. Johnston NL, Cervenak J, Shore AD, Torrey EF, Yolken RH, Cerevnak J. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium. J Neurosci Methods. 1997;77:83-92.
21. Gertz J, Varley KE, Davis NS, Baas BJ, Goryshin IY, Vaidyanathan R, et al. Transposase mediated construction of RNA-seq libraries. Genome Res. 2012;22:134-41.
22. Alonso A, Lasseigne BN, Williams K, Nielsen J, Ramaker RC, Hardigan AA, et al. aRNApipe: a balanced, efficient and distributed pipeline for processing RNA-seq data in high performance computing environments. Bioinformatics. 2017;33(11):1727-9.
23. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15-21.
24. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
25. Kim JH, Karnovsky A, Mahavisno V, Weymouth T, Pande M, Dolinoy DC, et al. LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types. BMC Genomics. 2012;13:526.
26. Isserlin R, Merico D, Voisin V, Bader GD. Enrichment Map-a Cytoscape app to visualize and explore OMICs pathway enrichment results. F1000Research. 2014;3:141.
27. Darmanis S, Sloan SA, Zhang Y, Enge M, Caneda C, Shuer LM, et al. A survey of human brain transcriptome diversity at the single cell level. Proc Natl Acad Sci U S A. 2015;112(23):7285-90.
28. Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2015;89:37-53.
29. Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O'Keeffe S, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34:11929-47.
30. Gong T, Szustakowski JD. DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data. Bioinformatics. 2013;29:1083-5.
31. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6:1060-83.
32. Hummel J, Strehmel N, Selbig J, Walther D, Kopka J. Decision tree supported substructure prediction of metabolites from GC-MS profiles. Metabolomics. 2010;6:322-33.
33. Castillo S, Mattila I, Miettinen J, Orešič M, Hyötyläinen T. Data analysis tool for comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry. Anal Chem. 2011;83:3058-67.
34. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545-50.
35. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci. 2015;18:199-209.
36. Vita A, De Peri L, Deste G, Sacchetti E. Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry. 2012;2, e190.
37. Berretta S, Pantazopoulos H, Lange N. Neuron numbers and volume of the amygdala in subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry. 2007;62:884-93.
38. Thompson M, Weickert CS, Wyatt E, Webster MJ. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J Psychiatr Res. 2009;43:970-7.
39. Skelly DA, Merrihew GE, Riffle M, Connelly CF, Kerr EO, Johansson M, et al. Integrative phenomics reveals insight into the structure of phenotypic diversity in budding yeast. Genome Res. 2013;23:1496-504.
40. Kim S, Hwang Y, Webster MJ, Lee D. Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders. Mol. Psychiatry. 2016;21(3):376-85. doi: 10.1038/mp.2015.79.
41. Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J, et al. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS One. 2012;7, e35367.
42. Sorenson SB. Gender disparities in injury mortality: consistent, persistent, and larger than you'd think. Am J Public Health. 2011;101:353-8.
43. Aubin H-J, Rollema H, Svensson TH, Winterer G. Smoking, quitting, and psychiatric disease: a review. Neurosci Biobehav Rev. 2012;36:271-84.
44. Wolock SL, Yates A, Petrill SA, Bohland JW, Blair C, Li N, et al. Gene × smoking interactions on human brain gene expression: finding common mechanisms in adolescents and adults. J Child Psychol Psychiatry. 2013;54:1109-19.
45. Weissman DH, Gopalakrishnan A, Hazlett CJ, Woldorff MG. Dorsal anterior cingulate cortex resolves conflict from distracting stimuli by boosting attention toward relevant events. Cereb Cortex. 2005;15:229-37.
46. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci. 2001;2:417-24.
47. Carter CS, Braver TS, Barch DM, Botvinick MM, Noll D, Cohen JD. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science. 1998;280:747-9.
48. Woo T-UW, Kim AM, Viscidi E. Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia. Brain Res. 2008;1218:267-77.
49. Yamada K, Gerber DJ, Iwayama Y, Ohnishi T, Ohba H, Toyota T, et al. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci U S A. 2007;104:2815-20.
50. Pérez-Santiago J, Diez-Alarcia R, Callado LF, Zhang JX, Chana G, White CH, et al. A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. J Psychiatr Res. 2012;46:1464-74.
51. Zhang L, Cho J, Ptak D, Leung YF. The role of egr1 in early zebrafish retinogenesis. PLoS One. 2013;8:1-11.
52. Baumgärtel K, Genoux D, Welzl H, Tweedie-Cullen RY, Koshibu K, Livingstone-Zatchej M, et al. Control of the establishment of aversive memory by calcineurin and Zif268. Nat Neurosci. 2008;11:572-8.
53. Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum. Eur J Pharmacol. 2009;620:27-35.
54. Xu Y, Yue W, Shugart YY, Li S, Cai L, Li Q, et al. Exploring transcription factors-microRNAs co-regulation networks in schizophrenia. Schizophr Bull. 2016;42:1037-45.
55. Koldamova R, Schug J, Lefterova M, Cronican AA, Fitz NF, Davenport FA, et al. Genome-wide approaches reveal EGR1-controlled regulatory networks associated with neurodegeneration. Neurobiol Dis. 2014;63:107-14.
56. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014;506:179-84.
57. Guillozet-Bongaarts AL, Hyde TM, Dalley RA, Hawrylycz MJ, Henry A, Hof PR, et al. Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry. 2014;19:478-85.